Last synced on 25 April 2025 at 11:05 pm

Reherniation Reduction Device

Page Type
Product Code
Definition
The device is intended to reduce the incidence of reherniation, and reoperation following primary limited lumbar discectomy procedures (excision of herniated intervertebral disc).
Physical State
The device is made of a metal component with a polymer mesh flap intended to cover the annular defect.
Technical Method
The device is intended to block the annular defect to prevent reherniation of nucleus material. The device also creates lesion in the vertebral body that may also prevent the herniation of the nucleus material out of the annulus.
Target Area
The device is implanted into the vertebral body and rests in the intervertebral space within the annulus.
Review Panel
Orthopedic
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QES to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Reherniation Reduction Device

Page Type
Product Code
Definition
The device is intended to reduce the incidence of reherniation, and reoperation following primary limited lumbar discectomy procedures (excision of herniated intervertebral disc).
Physical State
The device is made of a metal component with a polymer mesh flap intended to cover the annular defect.
Technical Method
The device is intended to block the annular defect to prevent reherniation of nucleus material. The device also creates lesion in the vertebral body that may also prevent the herniation of the nucleus material out of the annulus.
Target Area
The device is implanted into the vertebral body and rests in the intervertebral space within the annulus.
Review Panel
Orthopedic
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
Yes
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QES to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.